Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

June 29, 2024

Study Completion Date

May 6, 2025

Conditions
Bacterial VaginosisCandidosis VaginalUrinary Tract Infections
Interventions
DIETARY_SUPPLEMENT

Lacticaseibacillus rhamnosus CA15 (DSM 33960) probiotic strain

Patients allocated to the probiotic arm will take the dietary supplement, containing 10 billion of the Lacticaseibacillus rhamnosus CA15 (DSM 33960) probiotic strain, once a day for 10 consecutive days.

DIETARY_SUPPLEMENT

placebo

Patients allocated to placebo arm will take placebo capsules once a day for 10 consecutive days.

Trial Locations (1)

95123

University of Catania, Catania

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ProBioEtna

UNKNOWN

lead

Agnese Maria Chiara Rapisarda

OTHER